
Show Notes
In this episode of The Pathology Report, host Dr Mags Strauss talks with Dr Melinda Lerwill, faculty director of continuing education and accreditation at Harvard Medical School, and Prof Rosemary Balleine, a clinical professor at Westmead Institute for Medical Research and the University of Sydney, to explore recent advances in pathology in women’s health. From molecular diagnostics to digital pathology and multidisciplinary collaboration, they discuss how innovation is transforming care for women. Drawing on examples in breast and ovarian cancers, they highlight the importance of multidisciplinary collaboration driving better patient outcomes. They also touch on the emerging potential of digital pathology and AI in helping to improve diagnostic access and supporting remote care and reducing variation in interpretation. By identifying patterns and streamlining testing, AI promises to make diagnostics faster, more accurate and more widely available. Dr Lerwill and Prof Balleine emphasise that with pathology evolving at such a rapid pace, staying at the forefront of new tools, research and treatments is key to ensure pathologists can continue to deliver the highest standard of care for women. RCPA Members This podcast is an RCPA-endorsed CPD activity. Each episode gives you an opportunity to gain CPD hours in three easy steps: Step 1. Listen or watch the podcast here, on your favourite podcast channel or on YouTube Step 2. To claim your CPD hours, please complete and pass this short online quiz Step 3. Sit back and let us load your CPD hours into your CPD profile for you
The Pathology Report is produced by the Royal College of Pathologists of Australasia and is part of the Talking HealthTech Podcast Network. Learn more about the RCPA at rcpa.edu.au and discover other shows in the network at talkinghealthtech.com/podcast/network.
More from The Pathology Report
Thank you to our partner RCPAQAP for their support in producing this podcast episode.
Thank you to our partner Astellas for their support in producing this podcast episode.
What are the current trends and operational realities in the genetic diagnosis of inherited cardiovascular diseases?
Thank you to our partner Roche for their support in producing this podcast episode.
Thank you to our partner Bristol Myers Squibb (BMS) for their support in producing this podcast episode.